Quotes from Vegconomist, December 1, 2023
MyriaMeat, a biotech startup founded by researchers from the University of Göttingen, has recently emerged from stealth mode and is making a bold claim – they are capable of cultivating 100% “real meat” using stem cells.
The startup, which has its headquarters in both Munich and Göttingen, was established in the year 2022 with the purpose of applying patented medical technology that is considered “groundbreaking” to the field of food.
This technology, which has been developed over a period of more than 25 years and with a financial investment of over €40 million, is founded on the utilization of pluripotent stem cells (iPSC) and parthenogenetic stem cells. It allows for the cultivation of functional muscle tissue, and potentially even entire cuts of meat.
One distinguishing feature of our muscle cells is their exceptional capability to contract, a characteristic that mixed products lack. According to Florian Hüttner, CEO of MyriaMeat, this capability to train the cells and positions solidifies MyriaMeat’s position as a trailblazer in the cultivated meat production industry.
MyriaMeat differentiates itself from competitors who are working on hybrid products containing plant proteins by combining the worldwide exclusive license for this technology with state-of-the-art biotechnology, allowing them to grow 100% muscle.
